How can Biogen move beyond its Alzheimer's blowup? Listen for the clues

How can Biogen move beyond its Alzheimer's blowup? Listen for the clues

STAT Plus: How does Biogen move beyond its Alzheimer’s drug blowup? Listen for the clues

By ADAM FEUERSTEIN

RUBY WALLAU FOR STAT

On this week's earnings call, investors will be listening for what, if anything, management says about the biotech’s path forward.

READ MORE